Does flow cytometry crossmatch predict renal allograft outcome in patients with a negative antiglobulin crossmatch? Commentary

Nature Clinical Practice Nephrology

Volumn 3, Issue 3, 2007, Pages 136-137

  Cecka, J Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; IMMUNOGLOBULIN ANTIBODY;

BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

EID: 33847259654     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0405     Document Type: Note

References (5)

1. Cecka JM et al. (2005) Preformed cytotoxic antibodies in potential allograft recipients: recent data. Hum Immunol 66: 343-349
2. Gebel HM et al. (2003). Pretransplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs risk. Am J Transplant 3: 1488-1500
3. Karpinski M et al. (2001) Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 12: 2807-2814
4. Dmitrienko S et al. (2006) Sensitivity, specificity and predictive value of class I and class II anti-HLA antibodies detected by Luminex in patients undergoing renal transplantation [abstract 10-P]. Hum Immunol 67 (Suppl 1): S114
5. El-Awar N et al. (2005) HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 66: 989-997